ADIPOQ and type 2 diabetes mellitus: However, this improvement was similar among subjects who had or did not have remission of T2D, indicating that the cardiovascular benefits of the adiponectin/leptin ratio could be due to a reduction in body fat volume or biochemical changes associated with weight reduction [32].